lysine has been researched along with Spinal Fractures in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhaliwal, R; Ewing, SK; Schwartz, AV; Semba, RD; Vashishth, D | 1 |
| Chen, J; Ikram, MA; Uitterlinden, AG; van der Eerden, BCJ; Voortman, T; Waqas, K; Zillikens, MC | 1 |
| Inoue, D; Okazaki, R; Saito, M; Shiraki, M; Watanabe, R | 1 |
| Choi, YJ; Chung, Y-; Jin, Y; Kim, SH; Lee, JS; Ock, SY | 1 |
| Kuroda, T; Saito, M; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
| Miyakoshi, N | 1 |
| Bauer, DC; Black, DM; Cummings, SR; Feingold, KR; Garnero, P; Harris, TB; Hillier, TA; Resnick, HE; Schwartz, AV; Sellmeyer, DE; Strotmeyer, ES; Tylavsky, FA | 1 |
| Bertholon, C; Chapurlat, R; Gineyts, E; Munoz, F; Sornay-Rendu, E | 1 |
| Sugimoto, T; Yamaguchi, T; Yamamoto, M; Yamauchi, M | 1 |
| Sugimoto, T; Yamaguchi, T; Yamamoto, M; Yamauchi, M; Yano, S | 1 |
1 review(s) available for lysine and Spinal Fractures
| Article | Year |
|---|---|
[Changes in bone quality and strength with bone-forming agents].
Topics: Anabolic Agents; Animals; Arginine; Bone and Bones; Bone Density; Collagen; Compressive Strength; Female; Fractures, Stress; Glycation End Products, Advanced; Haplorhini; Humans; Lysine; Osteogenesis; Osteoporosis; Rats; Spinal Fractures; Teriparatide | 2016 |
9 other study(ies) available for lysine and Spinal Fractures
| Article | Year |
|---|---|
Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes.
Topics: Aged; Bone Density; Diabetes Mellitus, Type 2; Fractures, Bone; Humans; Lysine; Risk Factors; Spinal Fractures | 2022 |
Dietary Advanced Glycation End-Products (dAGEs) Intake and Bone Health: A Cross-Sectional Analysis in the Rotterdam Study.
Topics: Aged; Bone Density; Cross-Sectional Studies; Diet; Diet Surveys; Eating; Female; Femur Neck; Glycation End Products, Advanced; Humans; Logistic Models; Lumbar Vertebrae; Lysine; Male; Middle Aged; Netherlands; Odds Ratio; Osteoporotic Fractures; Prevalence; Prospective Studies; Spinal Fractures | 2020 |
Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Cohort Studies; Female; Femur Neck; Forced Expiratory Volume; Humans; Kyphosis; Lumbar Vertebrae; Lung; Lysine; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Respiratory Function Tests; Spinal Fractures; Vital Capacity | 2018 |
Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus.
Topics: Absorptiometry, Photon; Aged; Arginine; Biomarkers; Bone Density; Cancellous Bone; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporotic Fractures; Spinal Fractures | 2018 |
Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women.
Topics: Aged; Arginine; Body Mass Index; Bone Density; Cohort Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Japan; Logistic Models; Lysine; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Prevalence; Regression Analysis; Reproducibility of Results; Risk Factors; Spinal Fractures | 2013 |
Pentosidine and increased fracture risk in older adults with type 2 diabetes.
Topics: Aged; Arginine; Bone Density; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Humans; Incidence; Lysine; Male; Prevalence; Risk Factors; Spinal Fractures | 2009 |
Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Biomarkers; Bone Density; Epidemiologic Methods; Female; Hip Joint; Humans; Lumbar Vertebrae; Lysine; Middle Aged; Osteoporotic Fractures; Postmenopause; Spinal Fractures | 2010 |
Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
Topics: Age of Onset; Aged; Aged, 80 and over; Albuminuria; Arginine; Blood Glucose; Bone Density; Creatinine; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lysine; Male; Middle Aged; Postmenopause; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Risk Factors; Spinal Fractures | 2009 |
Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Diabetes Mellitus, Type 2; Female; Humans; Logistic Models; Lysine; Male; Middle Aged; Postmenopause; Spinal Fractures | 2008 |